Skip to content
n:ews

Tag: Boston Scientific

Business Company signal

Boston Scientific Falls on Sales Hit After Prior Cyberattack

Boston Scientific cut its full-year outlook for a third straight quarter after a cyberattack hurt third-quarter sales, which rose only 1.5% organically to $5.14 billion. Management said the incident reduced organic growth by about 300 basis points and earnings by roughly 7 cents a share. It now sees full-year revenue growth of 4.25%, down from 5.5% to 6.5%. Shares fell as much as 7.6%.